SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : T/FIF, a New Plateau

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: The Dodgy Ticker who wrote (433)4/15/2001 12:21:17 PM
From: scaram(o)uche  Read Replies (1) of 2243
 
Bob:

With VPHM, you have "drug-related" leverage backing three programs to provide wind in the sails. With lab equipment, one needs to carry sales to the bottom line before the investment will come back a long way. Yes, I feel that it's worth holding at this price. OTOH, companies with drug-related leverage are dirt cheap at the moment, and the ride will be better there for those who pick wisely and have the disposition/stomach to trade aggressively.

Here's how I summarized my sentiments a few weeks back..........
Message 15492343

OTOH, I agree with Tuck's sentiment that "trickle" plays are setting up as good long-term INVESTMENTS.

I like MDCC. However, I was surprised at the timing re. LJL. They moved aggressively and paid, IMO, a premium that was too large. Sobered me.

Rick
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext